Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Recall Of Millions Of Ellume COVID-19 Tests High-Risk Class I, FDA Says
It’s the second coronavirus diagnostic to be slapped with a class I recall label
Nov 10 2021
•
By
Shawn M. Schmitt
The recalled COVID-19 test from Ellume • Source: Alamy
More from Recalls
More from Policy & Regulation